| 1 (43) | Samsung Corp * | MUL |  |
| 2 (108) | Hoffmann-La Roche Ltd, United States | USA |  |
| 3 (109) | Genentech Inc | USA |  |
| 4 (120) | Sanofi, United States | USA |  |
| 5 (145) | AstraZeneca * | MUL |  |
| 6 (173) | GlaxoSmithKline * | MUL |  |
| 7 (176) | AstraZeneca, Sweden | SWE |  |
| 8 (177) | F Hoffmann-La Roche * | MUL |  |
| 9 (179) | Siemens AG, Germany | DEU |  |
| 10 (187) | Sanofi * | MUL |  |
| 11 (225) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA |  |
| 12 (237) | Sanofi, France | FRA |  |
| 13 (241) | Eli Lilly and Company, United States | USA |  |
| 14 (260) | Novo Nordisk * | MUL |  |
| 15 (270) | Johnson & Johnson, United States | USA |  |
| 16 (271) | Novartis * | MUL |  |
| 17 (274) | Eli Lilly * | MUL |  |
| 18 (284) | Bayer * | MUL |  |
| 19 (298) | Novo Nordisk A/S | DNK |  |
| 20 (310) | Medtronic Inc, USA | USA |  |
| 21 (321) | Bristol-Myers Squibb Company, United States | USA |  |
| 22 (323) | Bayer AG, Germany | DEU |  |
| 23 (326) | Siemens AG, China | CHN |  |
| 24 (329) | GlaxoSmithKline, United Kingdom | GBR |  |
| 25 (365) | Johnson & Johnson * | MUL |  |
| 26 (372) | Medtronic * | MUL |  |
| 27 (373) | Siemens * | MUL |  |
| 28 (388) | Siemens Healthineers, Germany | DEU |  |
| 29 (417) | Bristol-Myers Squibb Company * | MUL |  |
| 30 (464) | Pfizer * | MUL |  |
| 31 (473) | Boehringer Ingelheim, USA | USA |  |
| 32 (484) | Abbott Laboratories, United States | USA |  |
| 33 (506) | Amgen, USA | USA |  |
| 34 (524) | Boehringer Ingelheim * | MUL |  |
| 35 (528) | Abbott Laboratories * | MUL |  |
| 36 (552) | Merck & Co Inc, United States | USA |  |
| 37 (559) | Merck & Co Inc * | MUL |  |
| 38 (562) | Siemens Healthineers, China | CHN |  |
| 39 (565) | AstraZeneca, United States | USA |  |
| 40 (578) | Boehringer Ingelheim GmbH Germany | DEU |  |
| 41 (600) | Amgen * | MUL |  |
| 42 (602) | AstraZeneca, United Kingdom | GBR |  |
| 43 (611) | Janssen Biotech Inc | USA |  |
| 44 (613) | Pfizer Inc, United States | USA |  |
| 45 (624) | CaixaBank SA * | ESP |  |
| 46 (639) | Janssen | MUL |  |
| 47 (685) | Mitsubishi Corp * | MUL |  |
| 48 (762) | Siemens AG, USA | USA |  |
| 49 (771) | Siemens Healthineers, USA | USA |  |
| 50 (775) | Koninklijke Philips NV * | MUL |  |
| 51 (841) | Robert Bosch * | MUL |  |
| 52 (889) | Novartis, Switzerland | CHE |  |
| 53 (954) | Daiichi Sankyo Co Ltd, Japan | JPN |  |
| 54 (964) | Certara * | MUL |  |
| 55 (1003) | Bosch, Germany | DEU |  |
| 56 (1055) | Boston Scientific Corp * | MUL |  |
| 57 (1060) | Boston Scientific Corp, USA | USA |  |
| 58 (1098) | Novartis Pharmaceuticals, United States | USA |  |
| 59 (1259) | Daiichi Sankyo Co Ltd * | MUL |  |
| 60 (1260) | Keralty * | COL |  |
| 61 (1564) | Anima Holding SA * | BRA |  |
| 62 (1652) | General Electric Company * | MUL |  |
| 63 (1910) | Manipal Global Education Group * | MUL |  |
| 64 (2018) | GE Healthcare | MUL |  |
| 65 (2167) | GE Healthcare, United States | USA |  |
| 66 (2306) | Grupo Jose de Mello * | PRT |  |
| 67 (2414) | GE Healthcare, China | CHN |  |
|